Detalhe da pesquisa
1.
Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors.
Int J Mol Sci
; 24(7)2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046997
2.
Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.
Cancers (Basel)
; 14(3)2022 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158766
3.
The Role of Nutrients in Prevention, Treatment and Post-Coronavirus Disease-2019 (COVID-19).
Nutrients
; 14(5)2022 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267974
4.
Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization.
Sarcoma
; 2011: 842842, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21253510
5.
The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis.
Front Immunol
; 11: 1749, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33042107
6.
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy.
Front Oncol
; 9: 1146, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31799175
7.
A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting.
Mol Cancer Ther
; 12(10): 1981-93, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23939376
8.
Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.
PLoS One
; 7(9): e44806, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23049759
9.
Regulation of cell migration and invasion by specific modules of uPA: mechanistic insights and specific inhibitors.
Curr Drug Targets
; 12(12): 1761-71, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21707476
10.
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.
Mol Cancer Ther
; 8(9): 2708-17, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19706734